SpringWorks Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-13.49 | -268.1 | -94.97% | 9.04 | -249.25% |
| P/S |
|
13.98 | 55.96 | -75.02% |
|
|
| P/BV |
|
5.57 | 251.23 | -97.78% |
|
|
| P/FCF |
|
-19.35 | -193.71 | -90.01% |
|
|
| Ev/Ebitda |
|
-9.41 | 12.23 | -176.9% |
|
|
| Ev/S |
|
13.66 | 457.86 | -97.02% |
|
|
| Ev/FCF |
|
-14.53 | -232.19 | -93.74% |
|
|
| E/P |
|
-0.0741 | 0.0158 | -567.58% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-145.17 | -339.51 | -57.24% | -2282.95 | -93.64% |
| ROE |
|
-46.62 | 98.24 | -147.46% |
|
|
| ROA |
|
-39.32 | -5.02 | 682.86% |
|
|
| ROIC |
|
-44.93 | 1.2 | -3857.32% |
|
|
| ROS |
|
-134.73 | -298.06 | -54.8% |
|
|
| ROCE |
|
-71.3 | -0.0718 | 99236.71% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0284 | 0.9431 | -103.02% | -0.0208 | +37.04% |
| Nеt Debt/Ebitda |
|
0.2223 | 1.03 | -78.31% |
|
|
| Debt/Ratio |
|
0.0135 | 0.1785 | -92.45% |
|
|
| Debt/Equity |
|
0.2207 | 1.56 | -85.85% |
|
|
| Debt/Net Income |
|
-0.0307 | -1.48 | -97.93% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8478 | -100% | ||
| DSI |
|
0 | 0.2116 | -100% |
|
|
| Average dividend growth |
|
0 | 1.31 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4975 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.24 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
447.4 | -87.95 | -608.7% | ||
| Growth impulse Ebitda in 5 years |
|
504.63 | -156.19 | -423.09% | ||
| Growth impulse Net Income in 5 years |
|
476.19 | -172.49 | -376.07% | ||
| Growth impulse FCF in 5 years |
|
448.93 | -114.63 | -491.63% | ||
| Growth impulse EPS in 5 years |
|
234.81 | -121.56 | -293.16% |
IP Score
4.65/10
